Summary
Updated Aug 30, 2026
Daniel B. Soland files SEC Form 4 reports at ACADIA PHARMACEUTICALS INC (ACAD). 1 SEC Form 4 filing on record, dated 29 May 2025.
Recent Transactions
1Every recent SEC Form 4 transaction Daniel B. Soland has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Daniel B. Soland files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Mark C. Schneyer - $1.21M of ACAD open-market activity in the last 12 months
- James M. Daly - $671K of ACAD open-market activity in the last 12 months
- James Kihara - $603K of ACAD open-market activity in the last 12 months
- Elizabeth H.Z. Thompson - $506K of ACAD open-market activity in the last 12 months
- Adams Catherine Owen - $250K of ACAD open-market activity in the last 12 months
- Jennifer J. Rhodes - $245K of ACAD open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Daniel B. Soland?
Daniel B. Soland is a corporate insider of ACADIA PHARMACEUTICALS INC (ACAD). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Daniel B. Soland last file a Form 4?
The only primary Form 4 on record is dated 29 May 2025.
Where can I see all of Daniel B. Soland's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Daniel B. Soland and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
